BCM
XLRN

Bluefin Capital Management’s Acceleron Pharma XLRN Stock Holding History

Bluefin Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,987
Closed -$858K – 1123
2021
Q3 		$858K Buy
+4,987
New +$652K 0.09% 174

Bluefin Capital Management's XLRN Position: Q4 2021 in Review

Bluefin Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 4,987 shares — an estimated $858K sold.

Bluefin Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $858K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Bluefin Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Bluefin Capital Management sold 4,987 Acceleron Pharma shares in Q4 2021, an estimated $858K.
  • Bluefin Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Bluefin Capital Management's Acceleron Pharma position peaked at $858K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bluefin Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.